Join
Live feed
·
ANALYSTRatingvia Quantisnow
CAMP4 Therapeutics Corporation logo

Oppenheimer initiated coverage on CAMP4 Therapeutics with a new price target

ByQuantisnow·Wall Street's wire, on your screen.
CAMP· CAMP4 Therapeutics Corporation
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CAMP (CAMP4 Therapeutics Corporation) and more on Quantisnow.